Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Acoustic Droplet Ejection High-Resolution Mass Spectrometry Enables High-Throughput Analysis of Proteins in Complex Biologic and Vaccine Matrices
Analytical Chemistry
1 September 2026
Laro J.
All Open Access, Green
Non-clinical analysis of virus-like particles (VLP) containing SARS-CoV-2 vaccine antigens
Vaccine
19 April 2026
Guardalini L.G.O.
From bench to bedside: Unveiling the background and benefits of nanovaccines tested in clinics
Asian Journal of Pharmaceutical Sciences
February 2026
Egorova V.S.
Tuning the tropism and infectivity of SARS-CoV-2 virus-like particles for mRNA delivery
Nucleic Acids Research
24 March 2025
Yang Q.
Open Access
Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged ≥18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial
Expert Review of Vaccines
2025
Yang B.F.
Open Access
Next-Generation Nanoparticle-Enabled mRNA Vaccines in the Treatment of COVID-19
Critical Reviews in Therapeutic Drug Carrier Systems
2025
Kole E.
VLP (Virus-Like Particles) Vaccines – Current Knowledge and Future Directions
Brazilian Archives of Biology and Technology
2025
Meghana P.
Open Access
Engineered Virus-Like Particles (VLPs): A Modern Approach to Infectious Diseases and Metabolic Disorders
Malaysian Journal of Medicine and Health Sciences
December 2024
Rehman A.U.
Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection
Scientific Reports
December 2024
Chulanetra M.
Open Access
A substitution at the cytoplasmic tail of the spike protein enhances SARS-CoV-2 infectivity and immunogenicity
Ebiomedicine
December 2024
Li Y.
Open Access
Prokaryote- and Eukaryote-Based Expression Systems: Advances in Post-Pandemic Viral Antigen Production for Vaccines
International Journal of Molecular Sciences
November 2024
Khudainazarova N.S.
Open Access
Inducing Long Lasting B Cell and T Cell Immunity Against Multiple Variants of SARS-CoV-2 Through Mutant Bacteriophage Qβ—Receptor Binding Domain Conjugate
Advanced Healthcare Materials
7 August 2024
Tan Z.
Open Access
Vaccine delivery systems and administration routes: Advanced biotechnological techniques to improve the immunization efficacy
Vaccine X
August 2024
Bouazzaoui A.
Open Access
Modularized viromimetic polymer nanoparticle vaccines (VPNVaxs) to elicit durable and effective humoral immune responses
National Science Review
1 March 2024
Huang Z.
Open Access
Controlling the Quality of Nanodrugs According to Their New Property—Radiothermal Emission
Pharmaceutics
February 2024
Petrov G.V.
Open Access
Virus-like particles as powerful vaccination strategy against human viruses
Reviews in Medical Virology
January 2024
Hadj Hassine I.
COVID-19: The vaccine development strategies
Understanding the Pandemic Pathophysiology Transmission and Treatment of Covid 19
1 January 2024
Yan M.Z.
mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions
Vaccines
December 2023
Okuyama R.
Open Access
An Overview of SARS-CoV-2 Etiopathogenesis and Recent Developments in COVID-19 Vaccines
Biomolecules
November 2023
Mathew D.S.
Open Access
Viral protein-based nanoparticles (part 2): Pharmaceutical applications
European Journal of Pharmaceutical Sciences
1 October 2023
Mellid-Carballal R.
Open Access
Large-Scale Purification and Characterization of Recombinant Receptor-Binding Domain (RBD) of SARS-CoV-2 Spike Protein Expressed in Yeast
Vaccines
October 2023
Nagar G.
Open Access
COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic
Viruses
September 2023
Zasada A.A.
Open Access
An Overview of Recent Developments in the Application of Antigen Displaying Vaccine Platforms: Hints for Future SARS-CoV-2 VLP Vaccines
Vaccines
September 2023
Setyo Utomo D.I.
Open Access